Asima Zehgeer1, Golda S Ginsburg1, Phyllis Lee1, Boris Birmaher2, John Walkup3, Philip C Kendall4, Dara Sakolsky2, Tara Peris5. 1. University of Connecticut School of Medicine Department of Psychiatry, Farmington, CT. 2. University of Pittsburgh Medical Center Department of Psychiatry, Pittsburgh, PA. 3. Weill Cornell Medical College Department of Psychiatry New York, NY. 4. Temple University Department of Psychology, Philadelphia, PA. 5. University of California, Los Angeles Department of Psychiatry, Los Angeles, CA.
Abstract
BACKGROUND: Pharmacotherapy is considered an evidenced-based treatment for anxious youth. There is a need to better understand the relation between medication adherence and child outcomes. OBJECTIVE: This study prospectively examined:1) baseline predictors of adherence and 2) the relation between medication adherence and clinical outcomes in children and adolescents with anxiety disorders. METHODS: Participants were 349 youth randomized to sertraline, pill placebo, or sertraline plus cognitive behavioral therapy in the Child/Adolescent Anxiety Multimodal Study (CAMS) and followed over 12 weeks. The measure of pharmacotherapy adherence used was pharmacotherapist (PT) ratings of adherence at each session. Four domains of baseline predictors were examined (demographics, child clinical variables, family/parent variables, and treatment variables). RESULTS: Multiple regression analyses revealed few significant predictors of adherence. The most robust predictors of greater adherence were living with two parents and parents' positive expectations that medication would lead to better outcomes. Pharmacotherapists' ratings of higher adherence predicted higher global functioning at post treatment and treatment responder status. CONCLUSIONS: In order to increase adherence, improving expectations and instilling hope for positive outcomes and problem solving ways to overcome pragmatic barriers associated with single parent families is recommended.
BACKGROUND: Pharmacotherapy is considered an evidenced-based treatment for anxious youth. There is a need to better understand the relation between medication adherence and child outcomes. OBJECTIVE: This study prospectively examined:1) baseline predictors of adherence and 2) the relation between medication adherence and clinical outcomes in children and adolescents with anxiety disorders. METHODS: Participants were 349 youth randomized to sertraline, pill placebo, or sertraline plus cognitive behavioral therapy in the Child/Adolescent Anxiety Multimodal Study (CAMS) and followed over 12 weeks. The measure of pharmacotherapy adherence used was pharmacotherapist (PT) ratings of adherence at each session. Four domains of baseline predictors were examined (demographics, child clinical variables, family/parent variables, and treatment variables). RESULTS: Multiple regression analyses revealed few significant predictors of adherence. The most robust predictors of greater adherence were living with two parents and parents' positive expectations that medication would lead to better outcomes. Pharmacotherapists' ratings of higher adherence predicted higher global functioning at post treatment and treatment responder status. CONCLUSIONS: In order to increase adherence, improving expectations and instilling hope for positive outcomes and problem solving ways to overcome pragmatic barriers associated with single parent families is recommended.
Authors: Susan J Bartlett; Jerry A Krishnan; Kristin A Riekert; Arlene M Butz; Floyd J Malveaux; Cynthia S Rand Journal: Pediatrics Date: 2004-02 Impact factor: 7.124
Authors: John T Walkup; Anne Marie Albano; John Piacentini; Boris Birmaher; Scott N Compton; Joel T Sherrill; Golda S Ginsburg; Moira A Rynn; James McCracken; Bruce Waslick; Satish Iyengar; John S March; Philip C Kendall Journal: N Engl J Med Date: 2008-10-30 Impact factor: 91.245
Authors: Elizabeth Pappadopulos; Peter S Jensen; Alanna R Chait; L Eugene Arnold; James M Swanson; Laurence L Greenhill; Lily Hechtman; Shirley Chuang; Karen C Wells; William Pelham; Thomas Cooper; Glenn Elliott; Jeffrey H Newcorn Journal: J Am Acad Child Adolesc Psychiatry Date: 2009-05 Impact factor: 8.829
Authors: John T Walkup; Michael J Labellarte; Mark A Riddle; Daniel Pine; Laurence Greenhill; Rachel Klein; Mark Davies; Michael Sweeney; Caifeng Fu; Howard Abikoff; Sabine Hack; Brain Klee; James McCracken; Lindsey Bergman; John Piacentini; John March; Scott Compton; James Robinson; Thomas O'Hara; Sheryl Baker; Benedetto Vitiello; Louise Ritz; Margaret Roper Journal: J Am Acad Child Adolesc Psychiatry Date: 2003-01 Impact factor: 8.829
Authors: Scott N Compton; John T Walkup; Anne Marie Albano; John C Piacentini; Boris Birmaher; Joel T Sherrill; Golda S Ginsburg; Moira A Rynn; James T McCracken; Bruce D Waslick; Satish Iyengar; Phillip C Kendall; John S March Journal: Child Adolesc Psychiatry Ment Health Date: 2010-01-05 Impact factor: 3.033
Authors: Lesley A Norris; Lara S Rifkin; Thomas M Olino; John Piacentini; Anne Marie Albano; Boris Birmaher; Golda Ginsburg; John Walkup; Scott N Compton; Elizabeth Gosch; Philip C Kendall Journal: Child Psychiatry Hum Dev Date: 2019-12